Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/24/2026 | Q4 | $1.9B | -- | -- | $0.95 | -- |
| 10/30/2025 | Q3 | $2B | $1.9B | $0.90 | $0.95 | -$0.06 |
| 07/31/2025 | Q2 | $2.1B | $2B | $0.73 | $0.88 | -$0.15 |
| 05/06/2025 | Q1 | $2.1B | $2.1B | $0.88 | $0.86 | $0.02 |
| 02/24/2025 | Q4 | $2B | $2.1B | $0.57 | $0.82 | -$0.25 |
| 10/23/2024 | Q3 | $2B | $1.9B | $0.75 | $0.84 | -$0.09 |
| 07/24/2024 | Q2 | $1.9B | $1.8B | $0.79 | $0.79 | -$0.00 |
| 04/30/2024 | Q1 | $1.8B | $1.8B | $0.69 | $0.70 | -$0.01 |
| 02/20/2024 | Q4 | $1.8B | $1.7B | $0.16 | $0.69 | -$0.53 |
| 11/02/2023 | Q3 | $1.8B | $1.8B | -$0.16 | $0.74 | -$0.90 |
| 07/27/2023 | Q2 | -- | $1.8B | -$2.60 | -- | -- |
| 05/01/2023 | Q1 | -- | $1.7B | $0.56 | -- | -- |
| 02/16/2023 | Q4 | -- | $1.6B | $0.62 | -- | -- |
| 10/26/2022 | Q3 | -- | $1.6B | $0.49 | -- | -- |
| 08/02/2022 | Q2 | -- | $1.6B | $0.61 | -- | -- |
| 04/28/2022 | Q1 | -- | $1.7B | -$0.51 | -- | -- |
| 02/23/2022 | Q4 | -- | $2.5B | $0.50 | -- | -- |
| 10/28/2021 | Q3 | -- | $1.8B | $0.38 | -- | -- |
| 07/29/2021 | Q2 | -- | $1.5B | -$1.06 | -- | -- |
| 04/29/2021 | Q1 | -- | $1.5B | $0.33 | -- | -- |
| 02/22/2021 | Q4 | -- | $1.5B | $0.13 | -- | -- |
| 10/29/2020 | Q3 | -- | $1.4B | $0.37 | -- | -- |
| 08/06/2020 | Q2 | -- | $1.4B | -$0.27 | -- | -- |
| 04/29/2020 | Q1 | -- | $1.5B | -$0.73 | -- | -- |
| 02/20/2020 | Q4 | -- | $1.5B | $0.40 | -- | -- |
| 10/30/2019 | Q3 | -- | $1.4B | $0.39 | -- | -- |
| 07/31/2019 | Q2 | -- | $1.4B | $0.34 | -- | -- |
| 05/01/2019 | Q1 | -- | $1.3B | $0.28 | -- | -- |
| 02/26/2019 | Q4 | -- | $1.3B | $0.33 | -- | -- |
| 10/30/2018 | Q3 | -- | $1.3B | $0.38 | -- | -- |
| 07/30/2018 | Q2 | -- | $1.3B | $0.31 | -- | -- |
| 04/26/2018 | Q1 | -- | $1B | $0.99 | -- | -- |
| 02/23/2018 | Q4 | -- | $937M | $1.96 | -- | -- |
| 10/31/2017 | Q3 | -- | $1B | $0.32 | -- | -- |
| 08/02/2017 | Q2 | -- | $1.1B | $0.55 | -- | -- |
| 04/28/2017 | Q1 | -- | $1.1B | $0.26 | -- | -- |
| 02/24/2017 | Q4 | -- | $1.2B | -$0.61 | -- | -- |
| 11/01/2016 | Q3 | -- | $1.1B | -$0.44 | -- | -- |
| 07/29/2016 | Q2 | -- | $1B | $0.33 | -- | -- |
| 04/29/2016 | Q1 | -- | $996M | $0.30 | -- | -- |
| 02/26/2016 | Q4 | -- | $1.1B | $0.29 | -- | -- |
KBR, Inc. reported $1.9B worth of top line sales in its most recent quarter.
KBR, Inc. announced earnings per share of $0.90 which represents a miss of analyst forecast a $0.95 per share.
KBR, Inc. reported $270M that represents $2.11 per share over the last quarter.
KBR, Inc.'s earnings are forecast to grow from $2.79 per share to $3.25 per share next year representing an increase of 36.63%.
KBR, Inc.'s next earnings date is February 24, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.